Quarterly report pursuant to Section 13 or 15(d)

Unaudited Condensed Consolidated Statements of Operations

v3.8.0.1
Unaudited Condensed Consolidated Statements of Operations - USD ($)
3 Months Ended
Mar. 31, 2018
Mar. 31, 2017
Revenue:    
Consulting Revenue $ 135,485
Cost of Consulting Services Provided 85,363
Gross Margin 50,122
Operating Expenses    
General and administrative 2,223,590 1,208,303
Research and development 911,034 464,343
Total Operating Expenses 3,134,624 1,672,646
Other Operating Income and (Loss)    
Other income from joint venture 400,343
Equity in loss from joint venture (1,028,327)
Total Other Operating Income and Loss (627,984)
Operating Loss (3,762,608) (1,622,524)
Other Income and (Expenses)    
Interest income 23,557
Financing costs (982,436) (122,804)
Other income 20
Total Other Income and (Expenses) (958,879) (122,784)
Loss before income taxes (4,721,487) (1,745,308)
Income taxes
Net loss (4,721,487) (1,745,308)
Accumulated preferred stock dividend (112,902) (49,000)
Deemed additional dividend on preferred stock dividend due the beneficial conversion feature (31,134)
Deemed dividend on issuance of Series B convertible preferred stock due to beneficial conversion feature (2,624,836)
Net loss attributable to common stockholders $ (7,490,359) $ (1,794,308)
Net Loss Per Common Share, Basic and Diluted $ (0.39) $ (0.20)
Weighted Average Number of Common Shares Outstanding 19,231,578 9,138,014